Dr. Richard A. Larson describes what people with cancer should know about blood transfusions, including why a blood transfusion might be needed during cancer, the different types of transfusions, what to expect during a transfusion, and possible side effects.
2023 ASCO Annual Meeting Research Round Up: Progress in Preventing Melanoma Recurrence and Improving Equity in Cancer Care
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities.
Leukemia survivor Lewis Christie shares what it was like undergoing 2 bone marrow transplants to treat his cancer, the challenges he faced during recovery, and how his life has changed after transplant.
Dr. Amar Kelkar and Dr. Vincent Ho discuss what people with cancer and their caregivers should know about recovery in the weeks and months after a bone marrow transplant, including what follow-up care will be needed, what symptoms may occur, and how daily life may change.
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.
Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children.
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated.
Be The Match, the national bone marrow transplant registry, needs people of different racial and ethnic backgrounds to volunteer as donors. Learn why having diversity in the registry is important, what disparities exist, and how to sign up.
In this post, Rachel Engstrom describes how she learned to cope during her husband’s cancer diagnosis and after his death, including how she found support throughout the experience.